HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alice strain live attenuated influenza (H3N2) vaccin in an elderly population.

Abstract
The clinical and antibody responses to Alice strain (AS) live attenuated influenza A (H3N2) vaccine and killed parenteral (KP) bivalent influenza vaccine were compared in a randomly allocated group of 150 elderly volunteers. AS recipients experienced more symptoms but these were mild and short in duration. Rhinitis occurred in 45% and pain at injection site in 25% of the AS and KP groups, respectively. Influenza A (H3N2) serum hemmaglutination inhibition titer responses were significantly higher in KP vaccinees; 95% of KP AND 60% OF AS recipients with initial titers smaller than or equal to 1:16 had fourfold or greater titer rises. KP induced significantly higher nasal neutralization titers but the proportion with fourfold or greater responses was not significantly different. Previous studies have shown poor correlations between antibody levels induced by live influenza vaccines and protection. Natural and/or challenge studies are needed before efficacy of influenza vaccines can be established.
AuthorsL W Miller, E B Hume, F R O'Brien, Y Togo, R B Hornick
JournalAmerican journal of epidemiology (Am J Epidemiol) Vol. 101 Issue 4 Pg. 340-6 (Apr 1975) ISSN: 0002-9262 [Print] United States
PMID1168413 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antibodies, Viral
  • Influenza Vaccines
  • Vaccines, Attenuated
Topics
  • Aged
  • Animals
  • Antibodies, Viral (analysis)
  • Cell Line
  • Hemagglutination Inhibition Tests
  • Humans
  • Influenza Vaccines
  • Influenza, Human (diagnosis, immunology, prevention & control)
  • Kidney
  • Macaca mulatta
  • Neutralization Tests
  • Nose (immunology)
  • Vaccination
  • Vaccines, Attenuated

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: